Current position:Home >Product >
Carbamic acid, [2,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-2-oxo-1H-1, 4-benzodiazepin-3-yl]-, phenylmethyl ester
Carbamic acid, [2,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-2-oxo-1H-1, 4-benzodiazepin-3-yl]-, phenylmethyl ester(169504-69-2)
- Name: Carbamic acid, [2,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-2-oxo-1H-1, 4-benzodiazepin-3-yl]-, phenylmethyl ester
- Synonyms:
- Molecular Formula:C28H29N3O4
- Molecular Weight:
- CAS Registry Number:169504-69-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 169499-00-7/2,4-Thiazolidinedione, 5-(2-furanylmethylene)-3-phenyl-, 2-[(2-nitrophenyl)hydrazone]
- 169499-01-8/2,4-Thiazolidinedione, 5-(2-furanylmethylene)-3-phenyl-, 2-[(2,4-dinitrophenyl)hydrazone]
- 169504-47-6/Cyclohexanepropanamide, N-(2,3-dihydro-5-phenyl-2-thioxo-1H-1,4-benzodiazepin-3-yl)-
- 169504-48-7/Benzenepropanamide, 2,4-dichloro-N-(2,3-dihydro-5-phenyl-2-thioxo-1H-1,4-benzodiazepin-3- yl)-
- 169504-49-8/Cyclohexanepropanamide, N-[2-[(2-hydroxyethyl)amino]-5-phenyl-3H-1,4-benzodiazepin-3-yl]-
- 169504-51-2/Cyclohexanepropanamide, N-[2-(hydroxyamino)-5-phenyl-3H-1,4-benzodiazepin-3-yl]-, (E)-
- 169504-52-3/Cyclohexanepropanamide, N-[2-(hydroxyamino)-5-phenyl-3H-1,4-benzodiazepin-3-yl]-, (Z)-
- 169504-54-5/2H-1,4-Benzodiazepin-2-one, 5-(cyclohexylmethylamino)-1,3-dihydro-1-[(4-methoxyphenyl)methyl]-
- 169504-55-6/1H-1,4-Benzodiazepine-2,3-dione, 5-(cyclohexylmethylamino)-1-[(4-methoxyphenyl)methyl]-, 3-oxime
- 169504-56-7/Carbamic acid, [5-(cyclohexylmethylamino)-2,3-dihydro-1-[(4-methoxyphenyl)methyl]-2- oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
- 169504-57-8/1H-1,4-Benzodiazepine-2,3-dione, 5-(cyclohexylmethylamino)-1-[(4-methoxyphenyl)methyl]-, 3-[O-[(ethylamino)carbonyl]oxime]
- 169504-59-0/Carbamic acid, [5-(cyclohexylmethylamino)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3- yl]-, phenylmethyl ester
- 169504-61-4/Carbamic acid, [5-(cyclohexylmethylamino)-2,3-dihydro-2-thioxo-1H-1,4-benzodiazepin -3-yl]-, phenylmethyl ester
- 169504-62-5/2H-1,4-Benzodiazepine-2-thione, 3-amino-5-(cyclohexylmethylamino)-1,3-dihydro-
- 169504-64-7/Acetamide, 2-bromo-N-[2-(2-methyl-1-oxopropyl)phenyl]-
- 169504-65-8/2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-5-(1-methylethyl)-
- 169504-66-9/2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-
- 169504-67-0/1H-1,4-Benzodiazepine-2,3-dione, 1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-, 3-oxime
- 169504-68-1/2H-1,4-Benzodiazepin-2-one, 3-amino-1,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-
- 169504-69-2/Carbamic acid, [2,3-dihydro-1-[(4-methoxyphenyl)methyl]-5-(1-methylethyl)-2-oxo-1H-1, 4-benzodiazepin-3-yl]-, phenylmethyl ester
- 169504-70-5/Carbamic acid, [2,3-dihydro-5-(1-methylethyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
- 169504-71-6/2H-1,4-Benzodiazepine-2-thione, 3-amino-1,3-dihydro-5-(1-methylethyl)-, monohydrobromide
- 169504-86-3/Butane, 1-ethoxy-2-(methoxymethyl)-3,3-dimethyl-
- 169505-10-6/2-[2-(2-methylbutoxy)ethoxy]ethanol
- 169506-15-4/Ethanol, 2-(2-ethoxyphenoxy)-, methanesulfonate
- 169509-07-3/2,5-Furandione, dihydro-3-[1-[1-(4-methoxyphenyl)-2,4-dimethyl-5-phenyl-1H-pyrrol-3-yl] ethylidene]-4-(1-methylethylidene)-, (3E)-
- 169509-14-2/1,2-Benzenediamine, N,N,N',N'-tetrakis(3-methylphenyl)-
- 169512-18-9/Cyclohexanol, 4-(3-hydroxy-1-butenyl)-3,3,5-trimethyl-
- 169515-09-7/Phosphonic acid, [[2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-[(dimethylamino)methyl]ethoxy] methyl]-
- 169516-12-5/1,10-Phenanthroline-4,7-diamine, N,N,N',N'-tetramethyl-